Published in J Biol Chem on April 15, 1991
A Versatile Synthetic Extracellular Matrix Mimic via Thiol-Norbornene Photopolymerization. Adv Mater (2009) 3.07
Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br J Cancer (2006) 2.20
Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysis. Proc Natl Acad Sci U S A (2008) 2.13
Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell (2009) 1.79
Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels. Biomaterials (2009) 1.77
The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J (1994) 1.68
Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J (1993) 1.49
Direct visualization of protease activity on cells migrating in three-dimensions. Matrix Biol (2008) 1.42
Matrix metalloproteases: underutilized targets for drug delivery. J Drug Target (2007) 1.21
Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells. J Biol Chem (2007) 1.14
Matrix metalloproteases and PAR1 activation. Blood (2012) 1.05
Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor. Protein Sci (1995) 0.95
Local conformation and dynamics of isoleucine in the collagenase cleavage site provide a recognition signal for matrix metalloproteinases. J Biol Chem (2010) 0.94
Mapping proteolytic processing in the secretome of gastric cancer-associated myofibroblasts reveals activation of MMP-1, MMP-2, and MMP-3. J Proteome Res (2013) 0.89
Influence of telopeptides, fibrils and crosslinking on physicochemical properties of type I collagen films. J Mater Sci Mater Med (2009) 0.86
Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing. Protein Eng Des Sel (2012) 0.83
Phosphinic peptide analogues as potent inhibitors of Corynebacterium rathayii bacterial collagenase. Biochem J (1994) 0.83
Integrating valve-inspired design features into poly(ethylene glycol) hydrogel scaffolds for heart valve tissue engineering. Acta Biomater (2014) 0.82
Prospects and limitations of the rational engineering of fibrillar collagens. Protein Sci (2003) 0.82
Computational study of the catalytic domain of human neutrophil collagenase. specific role of the S3 and S'3 subsites in the interaction with a phosphonate inhibitor. J Comput Aided Mol Des (2002) 0.81
Regeneration of human dermis by a multi-headed peptide. J Invest Dermatol (2013) 0.77
Actinidain-hydrolyzed type I collagen reveals a crucial amino acid sequence in fibril formation. J Biol Chem (2010) 0.76
Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data. Protein Sci (1998) 0.76
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell (1999) 6.40
Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci U S A (2003) 5.50
The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A (1990) 4.46
A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int J Pept Protein Res (1990) 2.98
Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci U S A (1990) 2.68
Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides. Biopolymers (1996) 2.07
Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem (1997) 2.00
Detergent-activation of latent collagenase and resolution of its component molecules. Biochem Biophys Res Commun (1982) 1.91
Solid phase peptide synthesis of 15N-gramicidins A, B, and C and high performance liquid chromatographic purification. Int J Pept Protein Res (1989) 1.71
Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem (1991) 1.59
Characterization of collagenolytic activity from strains of Bacteroides gingivalis. J Periodontal Res (1988) 1.56
Solid-phase peptide synthesis and solid-state NMR spectroscopy of [Ala3-15N][Val1]gramicidin A. Proc Natl Acad Sci U S A (1988) 1.54
Tumor cell invasion, matrix metalloproteinases, and the dogma. Lab Invest (1994) 1.52
Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest (1994) 1.52
Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). J Biol Chem (1994) 1.49
Catabolism and turnover of collagens: collagenases. Methods Enzymol (1987) 1.44
Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin. Cancer Res (2000) 1.43
A continuous spectrophotometric assay for Clostridium histolyticum collagenase. Anal Biochem (1981) 1.42
Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases. J Biol Chem (2000) 1.35
Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity. J Biol Chem (2000) 1.32
Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation. J Biol Chem (2000) 1.31
Monoclonal antibodies to human fibroblast procollagenase. Inhibition of enzymatic activity, affinity purification of the enzyme, and evidence for clustering of epitopes in the NH2-terminal end of the activated enzyme. Biochemistry (1988) 1.30
Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase. J Biol Chem (1992) 1.28
Continuously recording fluorescent assays optimized for five human matrix metalloproteinases. Anal Biochem (1991) 1.28
Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis. J Dent Res (1997) 1.24
Sequence specificity of human skin fibroblast collagenase. Evidence for the role of collagen structure in determining the collagenase cleavage site. J Biol Chem (1987) 1.20
Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates. Biochemistry (2001) 1.19
Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J Biol Chem (1993) 1.16
Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: complementary digestion patterns. Biochemistry (1987) 1.14
Purification and separation of individual collagenases of Clostridium histolyticum using red dye ligand chromatography. Biochemistry (1984) 1.13
Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation. Proc Natl Acad Sci U S A (1998) 1.12
Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases. J Biol Chem (1992) 1.12
Micropatterning gradients and controlling surface densities of photoactivatable biomolecules on self-assembled monolayers of oligo(ethylene glycol) alkanethiolates. Chem Biol (1997) 1.11
Characterization of the individual collagenases from Clostridium histolyticum. Biochemistry (1984) 1.10
Human fibroblast collagenase-alpha-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian alpha-macroglobulins. J Biol Chem (1989) 1.10
Synthesis and release of procollagenase by cultured fibroblasts. J Biol Chem (1976) 1.09
CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol Biol Cell (1996) 1.07
Cellular recognition of synthetic peptide amphiphiles in self-assembled monolayer films. Biomaterials (1999) 1.07
A regulatory cascade involving retinoic acid, Cbfa1, and matrix metalloproteinases is coupled to the development of a process of perichondrial invasion and osteogenic differentiation during bone formation. J Cell Biol (2001) 1.07
Clostridium histolyticum collagenases: a new look at some old enzymes. Matrix Suppl (1992) 1.06
Purification of human matrilysin produced in Escherichia coli and characterization using a new optimized fluorogenic peptide substrate. Arch Biochem Biophys (1995) 1.05
Kinetics of acid demineralization in histologic technique. J Histochem Cytochem (1974) 1.05
Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry (1993) 1.04
Ligand accessibility as means to control cell response to bioactive bilayer membranes. J Biomed Mater Res (2000) 1.04
Substrate specificity of beta-collagenase from Clostridium histolyticum. J Biol Chem (1985) 1.04
Stable conformations of aliphatic disulfides: influence of 1,4 interactions involving sulfur atoms. Proc Natl Acad Sci U S A (1977) 1.03
Procollagenase from bovine gingiva. Biochim Biophys Acta (1976) 1.03
Construction of biologically active protein molecular architecture using self-assembling peptide-amphiphiles. Methods Enzymol (1997) 1.02
Proteins of the periodontium. Identification of collagens with the [alpha1(I)]2alpha2 and [alpha1(III)]3 structures in bovine periodontal ligament. J Biol Chem (1975) 1.01
Structure and dynamics of peptide-amphiphiles incorporating triple-helical proteinlike molecular architecture. Biochemistry (1999) 1.01
Elementary steps in the formation of horseradish peroxidase compound I: direct observation of compound 0, a new intermediate with a hyperporphyrin spectrum. Biochemistry (1989) 1.00
A peptide model of basement membrane collagen alpha 1 (IV) 531-543 binds the alpha 3 beta 1 integrin. J Biol Chem (1995) 0.99
Characterization of 58-kilodalton human neutrophil collagenase: comparison with human fibroblast collagenase. Biochemistry (1990) 0.98
Structure and expression of neutrophil gelatinase cDNA. Identity with type IV collagenase from HT1080 cells. J Biol Chem (1992) 0.98
Complementary substrate specificities of class I and class II collagenases from Clostridium histolyticum. Biochemistry (1985) 0.98
Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates. Bioorg Med Chem Lett (2003) 0.97
Comparison of the peroxidase reaction kinetics of prostaglandin H synthase-1 and -2. J Biol Chem (1999) 0.96
Activation of fibroblast procollagenase by mast cell proteases. Biochim Biophys Acta (1976) 0.95
Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. Biochemistry (1991) 0.95
Gelatinase A (MMP-2) activation by skin fibroblasts: dependence on MT1-MMP expression and fibrillar collagen form. Matrix Biol (2001) 0.95
Promotion of fibroblast adhesion by triple-helical peptide models of type I collagen-derived sequences. J Biol Chem (1996) 0.95
Chemical synthesis of proteins. Trends Biotechnol (2000) 0.94
Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation. J Biol Chem (2001) 0.94
Identification of Clostridium histolyticum collagenase hyperreactive sites in type I, II, and III collagens: lack of correlation with local triple helical stability. J Protein Chem (1992) 0.94
Hyperhydroxylation: a new strategy for neuronal targeting by venomous marine molluscs. Prog Mol Subcell Biol (2006) 0.94
Use of Edman degradation sequence analysis and matrix-assisted laser desorption/ionization mass spectrometry in designing substrates for matrix metalloproteinases. J Chromatogr A (2000) 0.94
Metal binding stoichiometry and mechanism of metal ion modulation of the activity of porcine kidney leucine aminopeptidase. Biochemistry (1981) 0.93
Production of three plasminogen activators and an inhibitor in keratinocyte cultures. Biochim Biophys Acta (1983) 0.93
Resonance Raman evidence for the activation of dioxygen in horseradish oxyperoxidase. J Biol Chem (1985) 0.93
Relationship between the individual collagenases of Clostridium histolyticum: evidence for evolution by gene duplication. Biochemistry (1984) 0.93
Trypsin activation of latent collagenase from several mammalian sources. Scand J Dent Res (1975) 0.93
Mechanism of inhibition of human neutrophil collagenase by Gold(I) chrysotherapeutic compounds. Interaction at a heavy metal binding site. J Biol Chem (1989) 0.92
Heme coordination of prostaglandin H synthase. J Biol Chem (1993) 0.92
Mutational analysis of residues in and around the active site of human fibroblast-type collagenase. J Biol Chem (1994) 0.92
Trifluoroacetic acid cleavage and deprotection of resin-bound peptides following synthesis by Fmoc chemistry. Methods Enzymol (1997) 0.92
Backbone and side-chain dynamics of residues in a partially folded beta-sheet peptide from platelet factor-4. Protein Sci (1997) 0.91
Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim Biophys Acta (1995) 0.91
Degradation of type I collagen by rat mucosal keratinocytes. Evidence for secretion of a specific epithelial collagenase. J Biol Chem (1987) 0.90
Proteolytic activity in developing bovine enamel. J Dent Res (1979) 0.90
An internal cysteine plays a role in the maintenance of the latency of human fibroblast collagenase. Biochemistry (1991) 0.90
CD7-mediated regulation of integrin adhesiveness on human T cells involves tyrosine phosphorylation-dependent activation of phosphatidylinositol 3-kinase. J Immunol (1997) 0.90
Novel inhibitors of procollagen C-terminal proteinase. Part 1: diamino Acid hydroxamates. Bioorg Med Chem Lett (2003) 0.90
Effect of ligand conformation on melanoma cell alpha3beta1 integrin-mediated signal transduction events: implications for a collagen structural modulation mechanism of tumor cell invasion. Biochemistry (1998) 0.90
Solid-phase synthesis and stability of triple-helical peptides incorporating native collagen sequences. Biopolymers (1993) 0.90
Induction of matrix metalloproteinases and a collagen-degrading phenotype in fibroblasts and epithelial cells by secreted Porphyromonas gingivalis proteinase. J Periodontal Res (1998) 0.90
Six-year study of peptide synthesis. Methods Enzymol (1997) 0.90
Melanoma cell adhesion and spreading activities of a synthetic 124-residue triple-helical "mini-collagen". J Biol Chem (1993) 0.89
Resonance Raman spectra of bovine liver catalase compound II. Similarity of the heme environment to horseradish peroxidase compound II. J Biol Chem (1989) 0.89